Verve Therapeutics Statistics
Total Valuation
TLV:RANI has a market cap or net worth of ILS 875.03 million. The enterprise value is 3.31 billion.
Market Cap | 875.03M |
Enterprise Value | 3.31B |
Important Dates
The next estimated earnings date is Thursday, August 21, 2025.
Earnings Date | Aug 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TLV:RANI has 175.29 million shares outstanding. The number of shares has increased by 16.80% in one year.
Current Share Class | 175.29M |
Shares Outstanding | 175.29M |
Shares Change (YoY) | +16.80% |
Shares Change (QoQ) | -30.84% |
Owned by Insiders (%) | 28.09% |
Owned by Institutions (%) | 17.52% |
Float | 73.20M |
Valuation Ratios
The trailing PE ratio is 11.73.
Price/FFO Ratio | n/a |
Price/AFFO Ratio | n/a |
PE Ratio | 11.73 |
Forward PE | n/a |
PS Ratio | 4.17 |
PB Ratio | 0.97 |
P/TBV Ratio | 0.98 |
P/FCF Ratio | n/a |
P/OCF Ratio | 20.66 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 45.46 |
EV / Sales | 15.81 |
EV / EBITDA | 62.54 |
EV / EBIT | 64.86 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 2.72.
Current Ratio | 0.88 |
Quick Ratio | 0.13 |
Debt / Equity | 2.72 |
Debt / EBITDA | 46.29 |
Debt / FCF | n/a |
Interest Coverage | 0.45 |
Financial Efficiency
Return on equity (ROE) is 10.37% and return on invested capital (ROIC) is 1.08%.
Return on Equity (ROE) | 10.37% |
Return on Assets (ROA) | 0.98% |
Return on Invested Capital (ROIC) | 1.08% |
Return on Capital Employed (ROCE) | 1.94% |
Revenue Per Employee | 3.13M |
Profits Per Employee | 1.09M |
Employee Count | 67 |
Asset Turnover | 0.06 |
Inventory Turnover | 0.41 |
Taxes
In the past 12 months, TLV:RANI has paid 25.62 million in taxes.
Income Tax | 25.62M |
Effective Tax Rate | 23.45% |
Stock Price Statistics
The stock price has increased by +74.42% in the last 52 weeks. The beta is 0.59, so TLV:RANI's price volatility has been lower than the market average.
Beta (5Y) | 0.59 |
52-Week Price Change | +74.42% |
50-Day Moving Average | 460.82 |
200-Day Moving Average | 433.68 |
Relative Strength Index (RSI) | 60.34 |
Average Volume (20 Days) | 178,226 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TLV:RANI had revenue of ILS 209.63 million and earned 72.89 million in profits. Earnings per share was 0.43.
Revenue | 209.63M |
Gross Profit | 108.28M |
Operating Income | 51.09M |
Pretax Income | 109.24M |
Net Income | 72.89M |
EBITDA | 52.98M |
EBIT | 51.09M |
Earnings Per Share (EPS) | 0.43 |
Balance Sheet
The company has 24.36 million in cash and 2.45 billion in debt, giving a net cash position of -2.43 billion or -13.85 per share.
Cash & Cash Equivalents | 24.36M |
Total Debt | 2.45B |
Net Cash | -2.43B |
Net Cash Per Share | -13.85 |
Equity (Book Value) | 901.72M |
Book Value Per Share | 4.57 |
Working Capital | -112.00M |
Cash Flow
Operating Cash Flow | 42.35M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 51.65%, with operating and profit margins of 24.37% and 34.77%.
Gross Margin | 51.65% |
Operating Margin | 24.37% |
Pretax Margin | 52.11% |
Profit Margin | 34.77% |
EBITDA Margin | 25.27% |
EBIT Margin | 24.37% |
FCF Margin | n/a |
Dividends & Yields
TLV:RANI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -16.80% |
Shareholder Yield | n/a |
Earnings Yield | 8.33% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 5 |